Leading a Private Equity Exit

Stuart McLachlan has taken Anthesis Group on a rapid growth trajectory since co-founding the sustainability consultancy in 2013. In this interview with Criticaleye’s Jacob Ambrose Willson, he discusses the recent transition to a new private equity owner with global ambitions for Anthesis.

Criticaleye supports senior leaders from a variety of businesses, sectors and geographies. With 83 percent of growth company executives in our research saying they are too inwardly focused, our global leadership Community provides a confidential and trusted space, offering diverse views which leaders can draw from when making decisions for themselves and their organisations.

Click here to find out how we support growth company executives and non-executives.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Inspiring Leaders Podcast: Su...

Martin Balaam, CEO of Pimberly and Jacqui Summons, NED/Fractional CHRO join Criticaleye's Senior Editor, Jacob Ambrose Willson to explore the demands of private equity ownership from driving value creation and manag...

Click here to download this insight
Adding Value as Chair

Experience counts in this business climate. Paul Lester talks to Criticaleye's Marc Barber about his career as a Chair across different asset classes and the ways in which a good Board can unlock value and support h...

Click here to download this insight
Positioning a Business for Ra...

Peter Sweetbaum has over two decades of experience leading high growth tech firms, often working in tandem with private equity owners. In this interview with Criticaleye, Peter explains his approach to scaling businesse...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 169




Aldermore Group NatWest Group Concentrix NATS Lightsource bp E.ON UK Workday Google Palo Alto Networks AlixPartners Rolls-Royce Hitachi Solutions British Land Drax Group plc Eightfold AI Accenture FTSE Women Leaders Review Salesforce IBM Consulting London Stock Exchange Group Legal & General GlaxoSmithKline plc Worldpay